A citation-based method for searching scientific literature

O Zhuchenko, J Bailey, P Bonnen, T Ashizawa, D W Stockton, C Amos, W B Dobyns, S H Subramony, H Y Zoghbi, C C Lee. Nat Genet 1997
Times Cited: 978



I A Klement, P J Skinner, M D Kaytor, H Yi, S M Hersch, H B Clark, H Y Zoghbi, H T Orr. Cell 1998
Times Cited: 686




List of shared articles



Times cited

Pathogenic mechanisms underlying spinocerebellar ataxia type 1.
Leon Tejwani, Janghoo Lim. Cell Mol Life Sci 2020
0

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
Anna Niewiadomska-Cimicka, Antoine Hache, Yvon Trottier. Front Neurosci 2020
2

Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
Swati Naphade, Kizito-Tshitoko Tshilenge, Lisa M Ellerby. Neurotherapeutics 2019
6

From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
Maria Pennuto, Carlo Rinaldi. Mol Cell Endocrinol 2018
8

Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.
Zi-Jian Wang, Aoife Hanet, Daniel Weishäupl, Inês M Martins, Anna S Sowa, Olaf Riess, Thorsten Schmidt. CNS Neurosci Ther 2018
9


Deregulation of RNA Metabolism in Microsatellite Expansion Diseases.
Chaitali Misra, Feikai Lin, Auinash Kalsotra. Adv Neurobiol 2018
4

Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer.
Andrea E Murmann, Jindan Yu, Puneet Opal, Marcus E Peter. Trends Cancer 2018
6

Keeping Our Calcium in Balance to Maintain Our Balance.
Melanie D Mark, Jan Claudius Schwitalla, Michelle Groemmke, Stefan Herlitze. Biochem Biophys Res Commun 2017
17

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
11